Sarah Cannon | Strategic Alliance Partners

Latest from Sarah Cannon


Experts Provide Real-World Advice for Molecular Testing in Gastrointestinal Malignancies

January 25, 2021

Johanna C. Bendell, MD, moderates a peer exchange with fellow experts to discuss differences in germline and somatic BRCA mutations in pancreatic cancer, the role of molecular testing in hepatocellular carcinoma, and treatment options for patients with BRAF-mutant, microsatellite instability–high colorectal cancer.

Johnson Assumes Director Post of Lung Cancer Research at Sarah Cannon Research Institute

January 12, 2021

Melissa Johnson, MD, shares her goals for the first 100 days as program director of the Lung Cancer Research at Sarah Cannon Research Institute, the current state of the anti-TIGIT antibody tiragolumab, and the future of lung cancer treatment.

x